top of page

Search

Cinnamtannin B-1 Inhibits the Progression of Osteosarcoma

Carrie Romero
Jan 24, 2024
1 min read

Cinnamtannin B-1 Inhibits the Progression of Osteosarcoma by Regulating the miR-1281/PPIF Axis

Recent Posts

Advancing Cancer Immunotherapy: CTD-1

Advancing Cancer Immunotherapy: CTD-1

GTS Biotech Receives Rare Pediatric Disease Designation from the FDA for CTB-1

GTS Biotech Receives Rare Pediatric Disease Designation from the FDA for CTB-1

FDA Grants Orphan Drug Designation to GTS Biotech’s CTB-1 as a Treatment for Osteosarcoma

FDA Grants Orphan Drug Designation to GTS Biotech’s CTB-1 as a Treatment for Osteosarcoma

bottom of page